 Conference Call Scheduled for Wednesday, July 27 at 4:30 p.m. Eastern Time SAN DIEGO , July 20, 2022 PRNewswire -- Viking Therapeutics, Inc. Viking NASDAQ: VKTX, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2022, after the market close on Wednesday, July 27, 2022. 